Davendra Segara

4.2k total citations
27 papers, 1.4k citations indexed

About

Davendra Segara is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Davendra Segara has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Davendra Segara's work include Breast Cancer Treatment Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Advanced Breast Cancer Therapies (5 papers). Davendra Segara is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Advanced Breast Cancer Therapies (5 papers). Davendra Segara collaborates with scholars based in Australia, United States and United Kingdom. Davendra Segara's co-authors include Robert L. Sutherland, Susan M. Henshall, Andrew V. Biankin, James G. Kench, Amanda Dawson, Wayne D. Tilley, Jonathan M. Harris, Carmela Ricciardelli, Elgene Lim and Gerhard A. Coetzee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Davendra Segara

26 papers receiving 1.4k citations

Peers

Countries citing papers authored by Davendra Segara

Since Specialization

Citations

This map shows the geographic impact of Davendra Segara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davendra Segara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davendra Segara more than expected).

Fields of papers citing papers by Davendra Segara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davendra Segara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davendra Segara. The network helps show where Davendra Segara may publish in the future.

Co-authorship network of co-authors of Davendra Segara

This figure shows the co-authorship network connecting the top 25 collaborators of Davendra Segara. A scholar is included among the top collaborators of Davendra Segara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davendra Segara. Davendra Segara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status 2022 ·Drug Design Development and Therapy ·(unknown), Fiona H. Zhou, Davendra Segara, Rinath Jeselsohn, Elgene Lim	38
2	Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer 2021 ·Genes ·(unknown), Lauren Brown, Andrew Parker, Davendra Segara, Neil Portman, (unknown), Elgene Lim	21
3	MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer 2020 ·Breast Cancer Research ·Neil Portman, Heloisa Milioli, Sarah Alexandrou, Rhiannon Coulson, (unknown), Kristine J. Fernandez, Kee Ming Chia, Ensar Halilovic, Davendra Segara, Andrew Parker, Sue Haupt, Ygal Haupt, Wayne D. Tilley, Alexander Swarbrick, C. Elizabeth Caldon, Elgene Lim	49
4	Estrogen receptor positive breast cancer patient–derived xenograft models in translational research 2020 ·Current Opinion in Endocrine and Metabolic Research ·Kee Ming Chia, (unknown), Sanjeev Kumar, Andrew Parker, Davendra Segara, Neil Portman, Elgene Lim	1
5	Understanding patient choices regarding breast reconstruction after mastectomy for breast cancer 2018 ·Supportive Care in Cancer ·Patsy S. Soon, (unknown), (unknown), (unknown), (unknown), Aashit Shah, Davendra Segara, S. Yarrow, Afaf Girgis	21
6	Efficacy of harmonic focus scalpel in seroma prevention after axillary clearance 2016 ·International Journal of Surgery ·(unknown), Rajkumar Cheluvappa, (unknown), S. Yarrow, Tony Pang, Davendra Segara, Patsy S. Soon	6
7	Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration 2011 ·PLoS ONE ·Emily K. Colvin, (unknown), James G. Kench, (unknown), Amanda Mawson, Mark Pinese, David K. Chang, Ilse Rooman, Sandra O’Toole, Davendra Segara, Elizabeth A. Musgrove, Robert L. Sutherland, Minoti V. Apte, Christopher J. Scarlett, Andrew V. Biankin	20
8	Can Breast MRI Predict Axillary Lymph Node Metastasis in Women Undergoing Neoadjuvant Chemotherapy 2010 ·Annals of Surgical Oncology ·Sara H. Javid, Davendra Segara, Parisa Lotfi, Sughra Raza, Mehra Golshan	53
9	Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer 2009 ·Cancer Research ·Amelia A. Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco‐Miotto, Margaret M. Centenera, Jonathan M. Harris, Shalini Jindal, Davendra Segara, Jia Li, Nicole L. Moore, Susan M. Henshall, Stephen N. Birrell, Gerhard A. Coetzee, Robert L. Sutherland, Lisa M. Butler, Wayne D. Tilley	309
10	The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy 2009 ·British Journal of Cancer ·Ern Yu Tan, (unknown), Leticia Campo, Chengcheng Han, Elena A. Takano, Helen Turley, Ida Candiloro, Francesco Pezzella, Kevin C. Gatter, Ewan K.A. Millar, Sandra A. O’Toole, Catriona M. McNeil, Paul Crea, Davendra Segara, R. Sutherland, Adrian L. Harris, Stephen B. Fox	165
11	Androgen receptor inhibits estrogen receptor-A activity and is prognostic in breast cancer 2009 ·Faculty of Health; Institute of Health and Biomedical Innovation ·Amelia A. Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco‐Miotto, Margaret M. Centenera, Jonathan M. Harris, Shalini Jindal, Davendra Segara, Jia Li, Nicole L. Moore, Susan M. Henshall, Stephen N. Birrell, Gerhard A. Coetzee, R.L. Sutherland, Lisa M. Butler, Wayne D. Tilley	0
12	Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease 2009 ·PLoS ONE ·Mark Pinese, Christopher J. Scarlett, James G. Kench, Emily K. Colvin, Davendra Segara, Susan M. Henshall, Robert L. Sutherland, Andrew V. Biankin	6
13	Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status 2009 ·International Journal of Cancer ·Niamh Murphy, Andrew V. Biankin, Ewan K.A. Millar, Catriona M. McNeil, Sandra O’Toole, Davendra Segara, Paul Crea, Monilola A. Olayioye, C. Soon Lee, Stephen B. Fox, Adrienne Morey, Michael Christie, Elizabeth A. Musgrove, Roger J. Daly, Geoffrey J. Lindeman, Susan M. Henshall, Jane E. Visvader, Robert L. Sutherland	14
14	Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma 2008 ·British Journal of Cancer ·Niamh Murphy, Christopher J. Scarlett, James G. Kench, Eleanor Y. M. Sum, Davendra Segara, Emily K. Colvin, (unknown), Peter H. Cosman, Cheok Soon Lee, Elizabeth A. Musgrove, Robert L. Sutherland, Geoffrey J. Lindeman, Susan M. Henshall, Jane E. Visvader, Andrew V. Biankin	18
15	Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? 2007 ·Journal of Surgical Oncology ·Davendra Segara, Ian E. Krop, Judy E. Garber, Eric P. Winer, Lyndsay Harris, Jennifer R. Bellon, Robyn L. Birdwell, Susan C. Lester, Stuart R. Lipsitz, J. Dirk Iglehart, Mehra Golshan	78
16	Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma 2007 ·PLoS ONE ·Marina Pasca di Magliano, Andrew V. Biankin, Patrick W. Heiser, David A. Cano, (unknown), Thérèse B. Deramaudt, Davendra Segara, Amanda Dawson, James G. Kench, Susan M. Henshall, Robert L. Sutherland, Andrzej A. Dlugosz, Anil K. Rustgi, Matthias Hebrok	172
17	Measurement of cardiac output with a non-invasive continuous wave Doppler device versus the pulmonary artery catheter: a comparative study 2006 ·Critical Care and Resuscitation ·(unknown), Davendra Segara, Priya Nair	21
18	Expression of HOXB2, a Retinoic Acid Signaling Target in Pancreatic Cancer and Pancreatic Intraepithelial Neoplasia 2005 ·Clinical Cancer Research ·Davendra Segara, Andrew V. Biankin, James G. Kench, (unknown), Amanda Dawson, (unknown), D. C. Gotley, Maxwell J. Coleman, Robert L. Sutherland, Susan M. Henshall	129
19	Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer 2005 ·Proceedings of the National Academy of Sciences ·Eleanor Y. M. Sum, Davendra Segara, (unknown), Mary L. Bath, Andrew Field, Robert L. Sutherland, Geoffrey J. Lindeman, Jane E. Visvader	76
20	EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer 2003 ·Oncogene ·Jennifer L. Clancy, Michelle J. Henderson, Amanda J. Russell, David W. Anderson, Ronaldo Bova, Ian Campbell, (unknown), Graeme A. Macdonald, Graham J. Mann, Tania Nolan, Ged Brady, Olufunmilayo I. Olopade, Erica Woollatt, (unknown), Davendra Segara, Neville F. Hacker, Susan M. Henshall, Robert L. Sutherland, Colin K. W. Watts	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact